Platelet proteome changes in dogs with congestive heart failure

dc.contributor.authorAkgün, Emel
dc.contributor.authorÇevik, Özge
dc.contributor.authorBaykal, Ahmet Tarık
dc.contributor.authorTanaka, Ryou
dc.contributor.authorCeron, Jose Joaquin
dc.contributor.buuauthorLevent, Pınar
dc.contributor.buuauthorKocatürk, Meriç
dc.contributor.buuauthorSarıl, Ahmet
dc.contributor.buuauthorYılmaz, Zeki
dc.contributor.departmentBursa Uludağ Üniversitesi/Veteriner Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0001-9836-0749
dc.contributor.researcheridV-5578-2017
dc.contributor.researcheridDDR-1481-2022
dc.contributor.researcheridT-4585-2019
dc.contributor.researcheridA-9637-2008
dc.contributor.scopusid56690616700
dc.contributor.scopusid36437200800
dc.contributor.scopusid57202390224
dc.contributor.scopusid35944810500
dc.date.accessioned2024-02-07T10:58:21Z
dc.date.available2024-02-07T10:58:21Z
dc.date.issued2020-11-30
dc.description.abstractBackground: Platelets play a central role in the development of cardiovascular diseases and changes in their proteins are involved in the pathophysiology of heart diseases in humans. There is lack of knowledge about the possible role of platelets in congestive heart failure (CHF) in dogs. Thus, this study aimed to investigate the changes in global platelet proteomes in dogs with CHF, to clarify the possible role of platelets in the physiopathology of this disease. Healthy-dogs (n = 10) and dogs with acute CHF due to myxomatous mitral valve disease (MMVD, n = 10) were used. Acute CHF was defined based on the clinical (increased respiratory rate or difficulty breathing) and radiographic findings of pulmonary edema. Dogs Blood samples were collected into tubes with acid-citrate-dextrose, and platelet-pellets were obtained by centrifuge and washing steps. Platelet-proteomes were identified using LC-MS based label-free differential proteome expression analysis method and matched according to protein database for Canis lupus familiaris. Results: Totally 104 different proteins were identified in the platelets of the dogs being 4 out of them were significantly up-regulated and 6 down-regulated in acute CHF dogs. Guanine-nucleotide-binding protein, apolipoproteins (A-II and C-III) and clusterin levels increased, but CXC-motif-chemokine-10, cytochrome-C-oxidase-subunit-2, cathepsin-D, serine/threonine-protein-phosphatase-PP1-gamma-catalytic-subunit, creatine-kinase-B-type and myotrophin levels decreased in acute CHF dogs. These proteins are associated with several molecular functions, biological processes, signaling systems and immune-inflammatory responses. Conclusion: This study describes by first time the changes in the protein composition in platelets of dogs with acute CHF due to MMVD. Our findings provide a resource for increase the knowledge about the proteome of canine platelets and their roles in CHF caused by MMVD and could be a tool for further investigations about the prevention and treatment of this disease.en_US
dc.identifier.citationLevent, P. vd. (2020). "Platelet proteome changes in dogs with congestive heart failure". BMC Veterinary Research, 16(1).en_US
dc.identifier.doihttps://doi.org/10.1186/s12917-020-02692-x
dc.identifier.eissn1746-6148
dc.identifier.issue1tr_TR
dc.identifier.pubmed33256720tr_TR
dc.identifier.scopus2-s2.0-85096940564tr_TR
dc.identifier.urihttps://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02692-x
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708215/
dc.identifier.urihttps://hdl.handle.net/11452/39584
dc.identifier.volume16tr_TR
dc.identifier.wos000596499800003
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherBMCtr_TR
dc.relation.bapDDP(V) - 2017/6tr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalBMC Veterinary Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPlatelet proteomicen_US
dc.subjectHeart failureen_US
dc.subjectMyxomatous mitral valve diseaseen_US
dc.subjectApolipoprotein C-IIIen_US
dc.subjectCardiac-hypertrophyen_US
dc.subjectAngiotensin-IIen_US
dc.subjectA-IIen_US
dc.subjectActivationen_US
dc.subjectMyotrophinen_US
dc.subjectDiseaseen_US
dc.subjectBiomarkersen_US
dc.subjectPhosphataseen_US
dc.subjectMortalityen_US
dc.subjectVeterinary sciencesen_US
dc.subjectDogsen_US
dc.subject.emtree4 (2 hydroxyethyl) 1 piperazineethanesulfonic aciden_US
dc.subject.emtreeAcetonitrileen_US
dc.subject.emtreeAcid citrate dextroseen_US
dc.subject.emtreeActinen_US
dc.subject.emtreeApolipoprotein Aen_US
dc.subject.emtreeApolipoprotein Cen_US
dc.subject.emtreeCathepsin Den_US
dc.subject.emtreeCitrate trisodiumen_US
dc.subject.emtreeCitric aciden_US
dc.subject.emtreeClusterinen_US
dc.subject.emtreeCreatine kinaseen_US
dc.subject.emtreeCyclic ampen_US
dc.subject.emtreeDependent protein kinaseen_US
dc.subject.emtreeCyclooxygenase 1 inhibitoren_US
dc.subject.emtreeCyclooxygenase 2 inhibitoren_US
dc.subject.emtreeCytochrome Ben_US
dc.subject.emtreeCytochrome C oxidaseen_US
dc.subject.emtreeDipeptidyl carboxypeptidase inhibitoren_US
dc.subject.emtreeDiuretic agenten_US
dc.subject.emtreeFibrinopeptide Ben_US
dc.subject.emtreeFibronectinen_US
dc.subject.emtreeGamma interferon inducible protein 10en_US
dc.subject.emtreeGelatinase Ben_US
dc.subject.emtreeGlucoseen_US
dc.subject.emtreeGuanine nucleotide binding proteinen_US
dc.subject.emtreeHeat shock proteinen_US
dc.subject.emtreeInotropic agenten_US
dc.subject.emtreeMagnesium sulfateen_US
dc.subject.emtreeMetalloproteinase inhibitoren_US
dc.subject.emtreePotassium chlorideen_US
dc.subject.emtreeProstaglandin e1en_US
dc.subject.emtreeProteomeen_US
dc.subject.emtreeRecombinant somatomedin Cen_US
dc.subject.emtreeSodium chlorideen_US
dc.subject.emtreeTroponin Len_US
dc.subject.emtreeProteomeen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAtrial fibrillationen_US
dc.subject.emtreeBreathing rateen_US
dc.subject.emtreeCell countingen_US
dc.subject.emtreeColor boppler echocardiographyen_US
dc.subject.emtreeCongestive heart failureen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCoughingen_US
dc.subject.emtreeDogen_US
dc.subject.emtreeDown regulationen_US
dc.subject.emtreeDyspneaen_US
dc.subject.emtreeEchocardiographyen_US
dc.subject.emtreeElectrocardiographyen_US
dc.subject.emtreeExercise toleranceen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHeart atrium enlargementen_US
dc.subject.emtreeHeart ejection fractionen_US
dc.subject.emtreeHeart failureen_US
dc.subject.emtreeHeart left ventricle contractionen_US
dc.subject.emtreeHeart left ventricle enddiastolic volumeen_US
dc.subject.emtreeHeart rateen_US
dc.subject.emtreeHeart rhythmen_US
dc.subject.emtreeHeart valveen_US
dc.subject.emtreeHeart ventricle hypertrophyen_US
dc.subject.emtreeHeart ventricle septum ruptureen_US
dc.subject.emtreeHeart ventricle sizeen_US
dc.subject.emtreeLeft ventricular fractional shorteningen_US
dc.subject.emtreeLiquid chromatography-mass spectrometryen_US
dc.subject.emtreeLung congestionen_US
dc.subject.emtreeLung edemaen_US
dc.subject.emtreeLung infiltrateen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMitral valve diseaseen_US
dc.subject.emtreeMitral valve regurgitationen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePleura effusionen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreeProtein analysisen_US
dc.subject.emtreeProtein expressionen_US
dc.subject.emtreeProtein interactionen_US
dc.subject.emtreeRespiratory distressen_US
dc.subject.emtreeReversed phase liquid chromatographyen_US
dc.subject.emtreeScoring systemen_US
dc.subject.emtreeSignal transductionen_US
dc.subject.emtreeSinus tachycardiaen_US
dc.subject.emtreeSystolic heart murmuren_US
dc.subject.emtreeThorax radiographyen_US
dc.subject.emtreeThrombocyteen_US
dc.subject.emtreeTime of flight mass spectrometryen_US
dc.subject.emtreeTransthoracic echocardiographyen_US
dc.subject.emtreeUpregulationen_US
dc.subject.emtreeVertebral heart scoreen_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeBlooden_US
dc.subject.emtreeDogen_US
dc.subject.emtreeDog diseaseen_US
dc.subject.emtreeHeart failureen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreeThrombocyteen_US
dc.subject.emtreeValvular heart diseaseen_US
dc.subject.emtreeVeterinary medicineen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBlood plateletsen_US
dc.subject.meshDog diseasesen_US
dc.subject.meshDogsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHeart failureen_US
dc.subject.meshHeart valve diseasesen_US
dc.subject.meshMaleen_US
dc.subject.meshProteomeen_US
dc.subject.scopusPimobendan; Mitral Valve Disease; Cavalier King Charles Spanielen_US
dc.subject.wosVeterinary sciencesen_US
dc.titlePlatelet proteome changes in dogs with congestive heart failureen_US
dc.typeArticleen_US
dc.wos.quartileQ1 (Veterinary sciences)en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Levent_vd_2020.pdf
Size:
763.11 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections